Literature DB >> 29275491

Vancomycin and tobramycin impregnated mineralized allograft for the surgical regenerative treatment of peri-implantitis: a 1-year follow-up case series.

José Nart1, Beatriz de Tapia1, Àngels Pujol1, Andrés Pascual1, Cristina Valles2.   

Abstract

OBJECTIVES: To assess the clinical and radiographic outcomes of the regenerative treatment of peri-implantitis using a vancomycin and tobramycin impregnated allograft (VTA) after a 12-month period.
MATERIAL AND METHODS: Thirteen consecutive patients who required a regenerative treatment of peri-implantitis were recruited. For the 17 implant sites, a flap was raised, and after mechanical and chemical implant decontamination, a vancomycin and tobramycin impregnated allograft was placed in the defect and then covered with a collagen membrane. Soft tissues were sutured allowing a non-submerged healing. Clinical and radiographic variables were evaluated at baseline and at 12 months after treatment.
RESULTS: No signs of continuous bone loss were observed and no implant was lost, yielding a 100% survival rate. All patient's clinical examination at 12 months revealed peri-implant health showing absence of suppuration and a statistically significant reduction in terms of bleeding on probing scores (70.6%, P = 0.001). Initial probing pocket depth (7.88 ± 1.22 mm) was significantly reduced at 12 months healing, a mean reduction of 4.23 ± 1.47 mm (P = 0.001) was achieved. The mean radiological infrabony defect at baseline reached 4.33 ± 1.62 mm, and was significantly reduced up to 0.56 ± 0.88 mm, which represents an 86.99 ± 18.2% bone fill from the original infrabony defect.
CONCLUSIONS: Within the limits of the study, the application of VTA with a collagen membrane yielded positive outcomes in terms of radiographic bone fill, pocket depth reduction, and attachment gain after a 12-month period. Thus, VTA plus a collagen membrane seem to be suitable for the regenerative treatment of peri-implantitis. CLINICAL RELEVANCE: The use of locally delivered antibiotic together with the bone graft may reduce the undesirable effects related to the systemic administration and the risk of resistances. In the light of the results obtained, these grafting materials might offer new treatment strategies in the surgical regenerative treatment of peri-implantitis.

Entities:  

Keywords:  Allograft; Antibiotic; Local antibiotic; Peri-implantitis; Regeneration; Surgical treatment

Mesh:

Substances:

Year:  2017        PMID: 29275491     DOI: 10.1007/s00784-017-2310-0

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  46 in total

1.  Implant surface characteristics influence the outcome of treatment of peri-implantitis: an experimental study in dogs.

Authors:  Jean-Pierre Albouy; Ingemar Abrahamsson; Leif G Persson; Tord Berglundh
Journal:  J Clin Periodontol       Date:  2010-11-24       Impact factor: 8.728

2.  Effect of cefazolin and vancomycin on osteoblasts in vitro.

Authors:  M L Edin; T Miclau; G E Lester; R W Lindsey; L E Dahners
Journal:  Clin Orthop Relat Res       Date:  1996-12       Impact factor: 4.176

3.  The plaque control record.

Authors:  T J O'Leary; R B Drake; J E Naylor
Journal:  J Periodontol       Date:  1972-01       Impact factor: 6.993

4.  Systemic antimicrobial therapy in osteomyelitis.

Authors:  Henry S Fraimow
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

5.  Treatment of peri-implantitis by local delivery of tetracycline. Clinical, microbiological and radiological results.

Authors:  A Mombelli; A Feloutzis; U Brägger; N P Lang
Journal:  Clin Oral Implants Res       Date:  2001-08       Impact factor: 5.977

6.  A follow-up study of peri-implantitis cases after treatment.

Authors:  Georgios Charalampakis; Per Rabe; Asa Leonhardt; Gunnar Dahlén
Journal:  J Clin Periodontol       Date:  2011-07-19       Impact factor: 8.728

7.  Anti-infective surgical therapy of peri-implantitis. A 12-month prospective clinical study.

Authors:  L J A Heitz-Mayfield; G E Salvi; A Mombelli; M Faddy; N P Lang
Journal:  Clin Oral Implants Res       Date:  2011-08-09       Impact factor: 5.977

Review 8.  The aminoglycosides.

Authors:  A Whelton
Journal:  Clin Orthop Relat Res       Date:  1984-11       Impact factor: 4.176

Review 9.  Surgical management of peri-implantitis: a systematic review and meta-analysis of treatment outcomes.

Authors:  Hsun-Liang Chan; Guo-Hao Lin; Fernando Suarez; Mark MacEachern; Hom-Lay Wang
Journal:  J Periodontol       Date:  2013-11-21       Impact factor: 6.993

Review 10.  Surgical treatment of peri-implantitis.

Authors:  Noel Claffey; Emily Clarke; Ioannis Polyzois; Stefan Renvert
Journal:  J Clin Periodontol       Date:  2008-09       Impact factor: 8.728

View more
  5 in total

Review 1.  A Systematic Review and Meta-Analysis of Systemic Antibiotic Therapy in the Treatment of Peri-Implantitis.

Authors:  Manuel Toledano-Osorio; Cristina Vallecillo; Raquel Toledano; Fátima S Aguilera; María T Osorio; Esther Muñoz-Soto; Franklin García-Godoy; Marta Vallecillo-Rivas
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

2.  The Osteogenic Effect of Local Delivery of Vancomycin and Tobramycin on Bone Marrow Stromal Cells.

Authors:  Lingjia Yu; Qi Fei; Jisheng Lin; Yong Yang; Yisheng Xu
Journal:  Infect Drug Resist       Date:  2020-07-01       Impact factor: 4.003

Review 3.  Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers.

Authors:  Saravanan Ramesh; Kavitha Govarthanan; Serge Ostrovidov; Haiguang Zhang; Qingxi Hu; Gulden Camci-Unal; Rama S Verma; Murugan Ramalingam
Journal:  Stem Cell Rev Rep       Date:  2021-04-16       Impact factor: 5.739

Review 4.  Current Insights in the Application of Bone Grafts for Local Antibiotic Delivery in Bone Reconstruction Surgery.

Authors:  Arne Peeters; Guy Putzeys; Lieven Thorrez
Journal:  J Bone Jt Infect       Date:  2019-10-15

Review 5.  Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications.

Authors:  Xiaofei Guo; Yan Bai; Li Zhang; Bo Zhang; Naufal Zagidullin; Katherine Carvalho; Zhimin Du; Benzhi Cai
Journal:  Stem Cell Res Ther       Date:  2018-02-26       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.